Detection of simian virus 40 DNA sequences in Egyptian patients with different hematological malignancies

References

• Carbone M, Kratzke R A, Testa J R. The pathogenesis of mesothelioma. Semin Oncol 2002; 29: 2–17
   PubMed Web of Science ®Google Scholar
• Shivapurkar N, Harada K, Reddy J, Scheuermann R H, Xu Y, McKenna R W, et al. Presence of simian virus 40 DNA sequences in human lymphomas. Lancet 2002; 359: 851–852
   PubMed Web of Science ®Google Scholar
• Vilchez R A, Madden C R, Kozinetz C A, Halvorson S J, White Z S, Jorgensen J L, et al. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 2002; 359: 817–823
   PubMed Web of Science ®Google Scholar
• Nakatsuka S, Liu A, Dong Z, Nomura S, Takakuwa T, Miyazato H, et al. Simian virus 40 sequences in malignant lymphomas in Japan. Cancer Res 2003; 63: 7606–7608
   PubMed Web of Science ®Google Scholar
• Diamandopoulos G T. Leukemia, lymphoma, and osteosarcoma induced in the Syrian golden hamster by simian virus 40. Science 1972; 176: 173–175
   PubMed Web of Science ®Google Scholar
• Rundell K, Parakati R. The role of the SV40 small t antigen in cell growth promotion and transformation. Semin Cancer Biol 2001; 11: 5–13
   PubMed Web of Science ®Google Scholar
• Rizzo P, Carbone M, Fisher S G, Matker C, Swinnen L J, Powers A, et al. Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin's lymphoma. Chest 1999; 116: 470S–473S
   PubMed Web of Science ®Google Scholar
• David H, Mendoza S, Konishi T, Miller C W. Simian virus 40 is present in human lymphomas and normal blood. Cancer Lett 2001; 162: 57–64
   PubMed Web of Science ®Google Scholar
• Fedele C G, Ciardi M, Delia S, Echevarria J M, Tenorio A. Multiplex polymerase chain reaction for the simultaneous detection and typing of polyomavirus JC, BK, and SV40 DNA in clinical samples. J Virol Methods 1999; 82: 137–144
   PubMed Web of Science ®Google Scholar
• Capello D, Rossi D, Gaudino G, Carbone A, Gaidano G. Simian virus 40 infection in lymphoproliferative disorders. Lancet 2003; 361: 88–89
   PubMed Web of Science ®Google Scholar
• MacKenzie J, Wilson K S, Perry J, Gallagher A, Jarett R F. Association between simian virus 40 DNA and lymphoma in the United Kingdom. J Natl Cancer Inst 2003; 95: 1001–1003
   PubMed Web of Science ®Google Scholar
• Jaffe E S, Harris N L, Stein H, Vardiman J W. World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Hematopoietic and Lymphoid Tissues. IARC Press, Lyon 2001
   Google Scholar
• Bahnassy A A, Zekri A-RN, El-Houssini S, Sedky L M, Mokhtar N M. Epstein Barr virus in head and neck extranodal non – Hodgkin's lymphoma in Egypt. Histopathology 2006; 48: 516–528
   PubMed Web of Science ®Google Scholar
• Sambrook J, Fritsch E F, Maniatis T. Analysis and cloning of eukarytic genomic DNA. A Laboratory Manual2nd ed, Cloning Molecular. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 1989; 1.21–1.52
   Google Scholar
• Butel J S. Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 2000; 21: 405–426
   PubMed Web of Science ®Google Scholar
• Butel J, Lednicky J. Cell and molecular biology of SV40: implications for human infections and disease. J Natl Cancer Inst 1999; 91: 119
   PubMed Web of Science ®Google Scholar
• Klein G, Powers A, Croce C M. Association of SV40 with human tumors. Oncogene 2002; 21: 1141–1149
   PubMed Web of Science ®Google Scholar
• Churg A, Roggli V, Galaleau-Salle F, Cagle Ph T, Gibbs A R, Hasleton Ph S, . Mesothelioma. World Health Organization Classification of Tumor Pathology and Genetics: Tumors of the Lung, Pleura, Thymus and Heart, W D Travis, E Brambilla, H K Muller-Hermelink, C C Harris, et al. IARC Press, Lyon 2004; 126–136
   Google Scholar
• Cristaudo A, Foddis R, Vivaldi A, Buselli R, Gattini V, Guglielmi G, et al. SV40 enhances the risk of malignant mesothelioma among people exposed to asbestos: a molecular epidemiologic case-control study. Cancer Res 2005; 65: 8
   Google Scholar
• Engels E A. Does simian virus 40 cause non-Hodgkin's lymphoma? A review of the laboratory and epidemiological evidence. Cancer Invest 2005; 23: 529–536
   PubMed Web of Science ®Google Scholar
• Shaikh S, Skoczylas C, Longnecker R, Rundell K. Inability of simian virus 40 to establish productive infection of lymphoblastic cell lines. J Virol 2004; 78: 4917–4920
   PubMed Web of Science ®Google Scholar
• Frank C, Mohamed M K, Strickland G T, Lavanchy D, Arthur R R, Magder L S, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000; 355: 887–891
   PubMed Web of Science ®Google Scholar
• Zekri A -RN, Bahnassy A A, Mohammed W S, Hassan N, Abdel-Rahman M A, Abou El-Kasem F, et al. Simian virus-40 as a biological prognostic factor in Egyptian patients with malignant pleural mesothelioma. Pathol Int 2007; 57: 493–501
   PubMed Web of Science ®Google Scholar
• Martini F, Dolcetti R, Gloghini A, Iaccheri L, Carbone A, Boiocchi M, et al. Simian virus 40 footprints in human lymphoproliferative disorders of HIV− and HIV+ patients. Int J Cancer 1998; 78: 669–674
   PubMed Web of Science ®Google Scholar
• Chen P M, Yen C C, Yang M H, Poh S B, Hsiao L T, Wang W S, et al. High prevalence of SV40 infection in patients with nodal non-Hodgkin's lymphoma but not acute leukemia independent of contaminated polio vaccines in Taiwan. Cancer Invest 2006; 24: 223–228
   PubMed Web of Science ®Google Scholar
• Liang R, Ma S Y. Higher incidence of Simian virus 40 in primary gastric diffuse large B cell lymphoma (DLBCL) than primary nodal disease in Chinese patients, but of no prognostic implication. J Clin Oncol 2004; 22: 6671
   Google Scholar